Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer

Alpha-methylacyl-CoA racemase (AMACR) is an enzyme playing an important role in the beta-oxidation of branched-chain fatty acids and fatty acid derivatives. High expression levels of AMACR have been described in various cancers, including prostate cancer, colorectal cancer and kidney cancer. Because...

Descripción completa

Detalles Bibliográficos
Autores principales: Honma, Ichiya, Torigoe, Toshihiko, Hirohashi, Yoshihiko, Kitamura, Hiroshi, Sato, Eiji, Masumori, Naoya, Tamura, Yasuaki, Tsukamoto, Taiji, Sato, Noriyuki
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797764/
https://www.ncbi.nlm.nih.gov/pubmed/20003233
http://dx.doi.org/10.1186/1479-5876-7-103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797764/
https://www.ncbi.nlm.nih.gov/pubmed/20003233
http://dx.doi.org/10.1186/1479-5876-7-103

Ejemplares similares